Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuDIMENSION: Nuwiq in Women/Girls With Haemophilia A Undergoing Surgery
NCT05936580Phase 4Recruiting
- Sponsor
- Octapharma
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 4 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started Apr 2026; status: recruiting.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT05936580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05936580.